- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel targeted therapies for Parkinson’s disease ; volume:27 ; number:1 ; day:25 ; month:2 ; year:2021 ; pages:1-20 ; date:12.2021
Molecular medicine ; 27, Heft 1 (25.2.2021), 1-20, 12.2021
- Creator
-
Ntetsika, Theodora
Papathoma, Paraskevi-Evita
Markaki, Ioanna
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-021-00279-2
- URN
-
urn:nbn:de:101:1-2021042220265466656360
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ntetsika, Theodora
- Papathoma, Paraskevi-Evita
- Markaki, Ioanna
- SpringerLink (Online service)
Other Objects (12)
Current and novel infusion therapies for patients with Parkinson's disease
ROS networks: designs, aging, Parkinson’s disease and precision therapies
Novel gene (TMEM230) linked to Parkinson’s disease
Advanced therapies in Parkinson’s disease: an individualized approach to their indication
Advanced therapies in Parkinson’s disease: an individualized approach to their indication
Gene and Cell-Based Therapies for Parkinson’s Disease: Where Are We?
Novel biomarkers and neuroimaging techniques in Parkinson’s disease
Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Current and novel infusion therapies for patients with Parkinson's disease
ROS networks: designs, aging, Parkinson’s disease and precision therapies
Novel gene (TMEM230) linked to Parkinson’s disease
Advanced therapies in Parkinson’s disease: an individualized approach to their indication
Advanced therapies in Parkinson’s disease: an individualized approach to their indication
Gene and Cell-Based Therapies for Parkinson’s Disease: Where Are We?
Novel biomarkers and neuroimaging techniques in Parkinson’s disease
Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Current and novel infusion therapies for patients with Parkinson's disease
ROS networks: designs, aging, Parkinson’s disease and precision therapies
Novel gene (TMEM230) linked to Parkinson’s disease
Advanced therapies in Parkinson’s disease: an individualized approach to their indication
Advanced therapies in Parkinson’s disease: an individualized approach to their indication
Gene and Cell-Based Therapies for Parkinson’s Disease: Where Are We?
Novel biomarkers and neuroimaging techniques in Parkinson’s disease
Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease